Edition:
United States

Insider Trading: Achillion Pharmaceuticals Inc (ACHN.O)

ACHN.O on Nasdaq

8.60USD
22 Jul 2016
Change (% chg)

-- (--)
Prev Close
$8.60
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,442,102
52-wk High
$10.95
52-wk Low
$5.57

All Insider Trades
Trading Date Name Title Type Shares Traded Price
25 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 120,000 $10.96
25 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 300,000 $11.12
24 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 131,800 $11.06
24 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 116,186 $11.01
24 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 250,000 $11.06
23 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 500,000 $11.28
23 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 319,100 $11.25
23 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 210,109 $11.29
23 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 175,720 $11.24
22 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 317,500 $11.02
22 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 11,783 $11.10
22 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 655,239 $11.11
21 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 335,140 $11.08
21 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 60,549 $11.09
21 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 50,000 $11.09
18 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 814,860 $11.50
18 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 327,713 $11.65
18 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 5,900 $11.84
18 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 16,387 $11.67
10 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 83,560 $12.62
10 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 531,352 $12.31
10 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 17,357 $12.32
10 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 250,000 $12.35
10 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 250,000 $12.35
10 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 17,357 $12.32

Institutional Holders

% Shares Owned: 86.27%
# of Holders: 219
Total Shares Held: 117,882,395
3 Mo. Net Change: -104,828
# New Positions: 3
# Closed Positions: 1
# Increased Positions: 12
# Reduced Positions: 6
# Net Buyers: 6

Officers & Directors

Name Age Since Current Position

David Scheer

63 2010 Chairman of the Board

Milind Deshpande

59 2013 President, Chief Executive Officer, Director

Mary Fenton

51 2015 Chief Financial Officer, Executive Vice President

Joel Barrish

58 2016 Executive Vice President, Chief Scientific Officer

Martha Manning

61 2016 Executive Vice President, General Counsel, Corporate Secretary

David Apelian

50 2013 Executive Vice President, Chief Medical Officer

Joseph Truitt

51 2014 Executive Vice President, Chief Commercial Officer

Amy Jennings

2016 Senior Vice President - Regulatory Affairs

Michael Kishbauch

66 2013 Director

Frank Verwiel

54 2015 Director

Jason Fisherman

58 2000 Independent Director

Gary Frashier

78 2008 Independent Director

Kurt Graves

48 2012 Independent Director

Robert Van Nostrand

58 2007 Independent Director

Nicole Vitullo

58 2010 Independent Director